platelet aggregation inhibitor

Term ID

CHEBI:50427

Synonyms

platelet aggregation inhibitors

Definition

A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: hematologic agent

hematologic agent Show first 5 Terms
has subtype: partial prostacyclin agonist platelet glycoprotein-IIb/IIIa receptor antagonist

partial prostacyclin agonist platelet glycoprotein-IIb/IIIa receptor antagonist Show first 5 Terms
inverse has_role: (E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside (E)-3-tosylacrylonitrile (S)-glaucine 2-acetamidophenol 4,4'-dihydroxybenzyl sulfone ... Show All 102 Terms

(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside (E)-3-tosylacrylonitrile (S)-glaucine 2-acetamidophenol 4,4'-dihydroxybenzyl sulfone 4-phenyl-3-furoxancarbonitrile 6-oxoprostaglandin E1 12-HPEPE 12-HPEPE(1-) acadesine acetylsalicylic acid ACT-333679 actinodaphnine aglafolin anagrelide anagrelide hydrochloride angelitriol angelol-J asperenone azelastine azelastine hydrochloride bassiatin BAY 41-2272 benzo[d]isothiazol-3-one beraprost beraprost sodium beta-benzoyloxypaeoniflorin bianfugenine bis-(4-hydroxybenzyl)ether cangrelor cangrelor tetrasodium carmoxirole carmoxirole hydrochloride cilostazol cis-ferulic acid clonixin clonixin lysine salt clopidogrel clopidogrel sulfate cyclomorusin A cytochalasin B delta-guaiene diallyl trisulfide dilazep dilazep dihydrochloride dipyridamole dithiadene droxicam edoxaban edoxaban tosylate edoxaban tosylate hydrate EET eptifibatide forskolin galgravin herquline A herquline B hydroxysafflor yellow A iloprost isobavachalcone isotanshinone IIB LFM-A13 lificiguat methyl brevifolincarboxylate milrinone milrinone lactate miroprofen ML355 N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide N-trans-cinnamoyltyramine neobavaisoflavone nisoldipine oleoyl danshenxinkun A oleoyl neocryptotanshinone procainamide prostaglandin E1 resolvin D5 S-nitroso-L-cysteine S-nitrosoglutathione sapinmusaponin Q sapinmusaponin R sciadopitysin selexipag sevoflurane SKF-96365 hydrochloride sophoraflavanone B splitomicin surfactin surfactin C syringetin taiwanin C tetramethylpyrazine ticagrelor ticlopidine treprostinil troglitazone vitexin vorapaxar vorapaxar sulfate xenocyloin yinyanghuo A yinyanghuo B Show first 5 Terms

Phenotype

Phenotype resulting from platelet aggregation inhibitor

Phenotype where environments contain platelet aggregation inhibitor

Phenotype modified by environments containing platelet aggregation inhibitor

Human Disease Model